3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia, Myeloid, Chronic-Phase
8
Leukemia
8
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Myeloproliferative Disorders
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Congenital Abnormalities
2
Thrombosis
1
Thrombocytosis
1
Polycythemia
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Bone Marrow Neoplasms
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
imetelstat
1
Vorinostat
1
Spectroscopy, Near-Infrared
1
Phlebotomy
1
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
1
Hydroxyurea
1
Histone Deacetylase Inhibitors
1
GRN163L peptide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycythemia
×
Hydroxyurea
×
Myeloid
×
Clear all
NCT01645124
2012-07-20
CYTO-PV
Consorzio Mario Negri Sud
Phase 3
Terminated
365 enrolled